Skip to main content
Year archive

Moberg Pharma — 2019 filings

All 83 regulatory filings released by Moberg Pharma (MOB) in 2019, sourced directly from the official regulator.

83 Filings
2019 Period
2019 filings (83)
Filing Released Lang
Major Shareholding Notification 2019
Major Shareholding Notification
2019-12-17 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-12-16 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-12-13 English
Moberg Pharma comments on the results of the North American Phase 3 study with MOB-015
Earnings Release FY 2019
2019-12-12 English
Moberg Pharma kommenterar resultaten i den nordamerikanska fas 3 studien med MOB-015
Legal Proceedings Report
2019-12-12 Swedish
Moberg Pharma uppnår det primära behandlingsmålet i fas 3 studie med MOB-015 för behandling av nagelsvamp
Earnings Release FY 2019
2019-12-09 Swedish
Moberg Pharma meets primary endpoint for MOB-015 in a Phase 3 study for the treatment of onychomycosis
Earnings Release FY 2019
2019-12-09 English
Reclassification of series B shares in Moberg Pharma AB (publ)
Share Issue/Capital Change
2019-11-29 English
Omstämpling av B-aktier i Moberg Pharma AB (publ)
Share Issue/Capital Change
2019-11-29 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q3 2020
2019-11-19 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-11-19 English
Moberg Pharmas delårsrapport för juli - september 2019 presenteras 19 november - Inbjudan till telefonkonferens
Report Publication Announcement
2019-11-12 Swedish
Moberg Pharma’s Interim report for July - September 2019 to be published on November 19 - Invitation to teleconference
Report Publication Announcement
2019-11-12 English
Bulletin from Moberg Pharma’s AGM on October 30th , 2019
AGM Information
2019-10-30 English
Kommuniké från Moberg Pharmas årsstämma den 30 oktober 2019
AGM Information
2019-10-30 Swedish
Moberg Pharma och DongKoo ingår avtal för MOB-015 i Sydkorea
Regulatory Filings
2019-10-21 Swedish
Moberg Pharma and DongKoo sign agreement for MOB-015 in the Republic of Korea
Regulatory Filings
2019-10-21 English
Changes to Moberg Pharma´s management team
Board/Management Information
2019-10-18 English
Förändring i ledningsgruppen i Moberg Pharma
Board/Management Information
2019-10-18 Swedish
Moberg Pharma and Taisho sign exclusive license agreement for MOB-015 in Japan
Regulatory Filings
2019-09-30 English
Moberg Pharma och Taisho ingår exklusivt licensavtal för MOB-015 i Japan
Regulatory Filings
2019-09-30 Swedish
Notice of Annual General Meeting in Moberg Pharma AB (publ)
AGM Information
2019-09-30 English
Kallelse till årsstämma i Moberg Pharma AB (publ)
AGM Information
2019-09-30 Swedish
The Nomination Committee’s proposal to the Annual General Meeting for the abbreviated fiscal year 2019
AGM Information
2019-09-19 English
Valberedningens förslag till årsstämman för det förkortade räkenskapsåret 2019
AGM Information
2019-09-19 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification
2019-09-13 English
Earnings Release 2019
Earnings Release H2 2019
2019-08-29 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report H2 2019
2019-08-29 English
Moberg Pharma’s Year-end report to be published on August 29 - Invitation to teleconference
Report Publication Announcement
2019-08-22 English
Moberg Pharmas bokslutskommuniké för 2019 presenteras 29 augusti - Inbjudan till telefonkonferens
Report Publication Announcement
2019-08-22 Swedish
Change in number of shares and votes in Moberg Pharma AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2019-07-31 English
Förändring av antalet aktier och röster i Moberg Pharma
Share Issue/Capital Change
2019-07-31 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification
2019-07-10 English
Moberg Pharmas valberedning utsedd
Regulatory Filings
2019-06-25 Swedish
Moberg Pharma´s nomination committee appointed
AGM Information
2019-06-25 English
Kommuniké från Moberg Pharmas årsstämma 2019
AGM Information
2019-05-15 Swedish
Bulletin from Moberg Pharma’s AGM 2019
AGM Information
2019-05-15 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements
2019-05-15 English
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-05-14 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-05-14 English
Moberg Pharmas rapport för första kvartalet presenteras 14 maj - Inbjudan till telefonkonferens
Report Publication Announcement
2019-05-07 Swedish
Moberg Pharma’s report for the first quarter to be published on May 14 - Invitation to teleconference
Report Publication Announcement
2019-05-07 English
Ändring av antalet aktier och röster i Moberg Pharma AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2019-04-30 Swedish
New number of shares and votes in Moberg Pharma AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2019-04-30 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-04-26 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements
2019-04-24 English
Annual Report 2018
Annual Report FY 2018
2019-04-16 English
Annual Report 2018
Annual Report FY 2018
2019-04-16 Swedish
­­Kallelse till årsstämma i Moberg Pharma AB (publ)
AGM Information
2019-04-10 Swedish
Notice of Annual General Meeting in Moberg Pharma AB (publ)
AGM Information
2019-04-10 English
Proposed management changes at Moberg Pharma
Board/Management Information
2019-04-08 English
Föreslagna ledningsförändringar i Moberg Pharma
Board/Management Information
2019-04-08 Swedish
Moberg Pharma påkallar förtida inlösen av obligationer med ISIN SE0007953989
Capital/Financing Update
2019-04-01 Swedish
Moberg Pharma gives notice of early redemption of bonds with ISIN SE0007953989
Capital/Financing Update
2019-04-01 English
Moberg Pharma slutför avyttringen av OTC-verksamheten för 155 miljoner USD
M&A Activity
2019-03-29 Swedish
Moberg Pharma completes the divestment of the OTC-business for USD 155 million
M&A Activity
2019-03-29 English
Moberg Pharma completes enrollment for MOB-015 Phase 3 study in Europe
Regulatory Filings
2019-03-22 English
Moberg Pharma slutför rekryteringen till fas 3-studien för MOB-015 i Europa
Regulatory Filings
2019-03-22 Swedish
Kommuniké från Moberg Pharmas extra bolagsstämma den 15 mars 2019
AGM Information
2019-03-15 Swedish
Bulletin from Moberg Pharma’s Extraordinary General Meeting 15 March 2019
AGM Information
2019-03-15 English
Moberg Pharma publicerar informationshandling med anledning av den föreslagna avyttringen av OTC-verksamheten
Transaction in Own Shares
2019-03-04 Swedish
Moberg Pharma publishes information document on the proposed divestment of the OTC-business
M&A Activity
2019-03-04 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-02-21 English
Kallelse till extra bolagsstämma i Moberg Pharma AB (publ)
AGM Information
2019-02-13 Swedish
Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)
AGM Information
2019-02-13 English
Earnings Release 2018
Earnings Release FY 2018
2019-02-12 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report FY 2018
2019-02-12 English
Moberg Pharma avyttrar OTC-verksamhet för 155 miljoner USD och tillför ny finansiering för MOB-015 i transformerande transaktion
M&A Activity
2019-02-12 Swedish
Moberg Pharma divests its OTC-business for USD 155 million and secures new funding for MOB-015 in transformational transaction
M&A Activity
2019-02-12 English
Moberg Pharma and Bayer sign exclusive license agreement for MOB-015 in Europe
Capital/Financing Update
2019-02-11 English
Moberg Pharma och Bayer ingår exklusivt licensavtal för MOB-015 i Europa
Capital/Financing Update
2019-02-11 Swedish
Moberg Pharmas bokslutskommuniké presenteras 12 februari - Inbjudan till telefonkonferens
Earnings Release FY 2018
2019-02-05 Swedish
Moberg Pharma’s Year-end report to be published on February 12 - Invitation to teleconference
Report Publication Announcement
2019-02-05 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-31 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-30 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-29 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-28 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-25 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-23 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-21 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-16 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-08 English
Moberg Pharma utökar ledningsgruppen
Board/Management Information
2019-01-08 Swedish